You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-4. Characteristics of new clients entering treatment: demographics and primary drug at treatment in 2005 or most recent year available [see all tables in this series...]

Part (i) Demographics

Country		Year	No. of clients	Mean age	% Age <25	% Age 35+	% Male
Bulgaria		2005	388	22.4	73.5	1.3	82.2
Czech Republic		2005	4372	22.9	68.6	6.2	68.2
Denmark		2005	1578	27.5	47.8	20.2	75.4
Germany		2005	14033	25.1	62.3	11.5	82.0
Ireland		2005	2007	26.9	57.7	9.7	78.9
Greece		2005	2225	29.5	36.1	19.0	84.5
Spain	(1)	2004	26169	29.5	34.8	26.9	82.5
France		2005	4167	24.2	62.8	9.6	82.1
Italy		2005	35175	30.0	29.5	30.1	86.3
Cyprus		2005	209	26.1	49.3	15.8	85.6
Latvia		2005	401	22.2	69.6	9.5	76.0
Lithuania		2005	349	26.3	46.4	13.2	78.2
Luxembourg	(2)	2005	383	30.0			70.0
Hungary		2005	6319	25.2	55.0	13.0	74.0
Malta		2005	312	23.5	67.6	10.9	83.0
Netherlands		2005	4299	28.8	40.2	26.0	78.7
Austria		2005	873	26.4	50.9	16.3
Poland	(1)	2004	6940	26.0	61.3	17.4	76.0
Portugal		2005	4844	31.0	20.7	36.0	85.3
Romania		2005	653	32.3	52.0	23.0	70.0
Slovenia	(1)	2004	526	23.1	68.0	5.0	75.6
Slovakia		2005	963	23.7	69.7	6.7	80.2
Finland		2005	631	24.4	64.0	11.0	68.0
Sweden		2005	1337	31.7	39.5	34.1	64.3
United Kingdom		2005	42923	29.4	37.0	25.7	71.5
Turkey		2005	939	27.9	40.0	20.0	92.3

Notes:

Data were not available for: Belgium, Estonia, Norway.

(1) Last data available refer to 2004.

(2) Data refer to all clients in treatment.

See also 'General notes for interpreting data' on the Explanatory notes and help page.

Sources:

2006 Reitox national reports - Standard table 3 See [Table TDI-1] for details on sources.